This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bass, D. M.
Right arrow Articles by Qiu, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bass, D. M.
Right arrow Articles by Qiu, S.

 Previous Article  |  Next Article 

Journal of Virology, February 2000, p. 1810-1814, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Proteolytic Processing of the Astrovirus Capsid

D. M. Bass* and Shiqiang Qiu

Department of Pediatrics, Stanford University, Stanford, California 94305

Received 16 July 1999/Accepted 22 November 1999

To further characterize the nature of proteolytic processing of the astrovirus capsid, we infected Caco-2 cells with a high multiplicity of astrovirus without trypsin in the presence of 5 to 10% fetal calf serum. These infections were characterized by pulse-chase labeling with [35S]methionine, electron microscopy, gel electrophoresis of purified viral particles, and analysis of infectivity of such particles with and without added trypsin. Pulse-chase experiments showed that the astrovirus capsid protein was initially translated as an approximately 87-kDa protein. The 87-kDa capsid protein was rapidly converted intracellularly to a 79-kDa form which was found in smaller amounts in the cell supernatant. Purification by differential centrifugation yielded particles that appeared quite similar to trypsin-grown astrovirus particles by negatively stained electron microscopy. These particles were antigenically distinct from trypsin-treated virions as demonstrated by their various reactions with monoclonal antibodies in a solid-phase immunoassay. The purified trypsin-free particles were mainly composed of the 79-kDa capsid protein which was found to have an amino terminus at residue 71 of the entire open reading frame 2 (ORF2) product. The cleavage site was identified in a highly conserved region of the astrovirus ORF2 product. These trypsin-free particles were minimally infectious in cultured Caco-2 cells but became highly infectious (105-fold increase) after trypsin but not chymotrypsin treatment. This trypsin-enhanced infectivity correlated with conversion of the 79-kDa capsid protein to three smaller peptides of approximately 34, 29, and 26 kDa.


* Corresponding author. Mailing address: Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305. Phone: (650) 723-5070. Fax: (650) 724-3106. E-mail: Dorsey.Bass{at}Forsythe.Stanford.edu.


Journal of Virology, February 2000, p. 1810-1814, Vol. 74, No. 4
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bonaparte, R. S., Hair, P. S., Banthia, D., Marshall, D. M., Cunnion, K. M., Krishna, N. K. (2008). Human Astrovirus Coat Protein Inhibits Serum Complement Activation via C1, the First Component of the Classical Pathway. J. Virol. 82: 817-827 [Abstract] [Full Text]  
  • Moser, L. A., Carter, M., Schultz-Cherry, S. (2007). Astrovirus Increases Epithelial Barrier Permeability Independently of Viral Replication. J. Virol. 81: 11937-11945 [Abstract] [Full Text]  
  • Mendez, E., Aguirre-Crespo, G., Zavala, G., Arias, C. F. (2007). Association of the Astrovirus Structural Protein VP90 with Membranes Plays a Role in Virus Morphogenesis. J. Virol. 81: 10649-10658 [Abstract] [Full Text]  
  • Caballero, S., Guix, S., Ribes, E., Bosch, A., Pinto, R. M. (2004). Structural Requirements of Astrovirus Virus-Like Particles Assembled in Insect Cells. J. Virol. 78: 13285-13292 [Abstract] [Full Text]  
  • Mittelholzer, C., Hedlund, K.-O., Englund, L., Dietz, H.-H., Svensson, L. (2003). Molecular characterization of a novel astrovirus associated with disease in mink. J. Gen. Virol. 84: 3087-3094 [Abstract] [Full Text]  
  • Mendez, E., Salas-Ocampo, M. P. E., Munguia, M. E., Arias, C. F. (2003). Protein Products of the Open Reading Frames Encoding Nonstructural Proteins of Human Astrovirus Serotype 8. J. Virol. 77: 11378-11384 [Abstract] [Full Text]  
  • Dalton, R. M., Pastrana, E. P., Sanchez-Fauquier, A. (2003). Vaccinia Virus Recombinant Expressing an 87-Kilodalton Polyprotein That Is Sufficient To Form Astrovirus-Like Particles. J. Virol. 77: 9094-9098 [Abstract] [Full Text]  
  • Mendez, E., Fernandez-Luna, T., Lopez, S., Mendez-Toss, M., Arias, C. F. (2002). Proteolytic Processing of a Serotype 8 Human Astrovirus ORF2 Polyprotein. J. Virol. 76: 7996-8002 [Abstract] [Full Text]  
  • Golden, J. W., Linke, J., Schmechel, S., Thoemke, K., Schiff, L. A. (2002). Addition of Exogenous Protease Facilitates Reovirus Infection in Many Restrictive Cells. J. Virol. 76: 7430-7443 [Abstract] [Full Text]  
  • Geigenmuller, U., Ginzton, N. H., Matsui, S. M. (2002). Studies on intracellular processing of the capsid protein of human astrovirus serotype 1 in infected cells. J. Gen. Virol. 83: 1691-1695 [Abstract] [Full Text]  
  • Jonassen, C. M., Jonassen, T. O., Saif, Y. M., Snodgrass, D. R., Ushijima, H., Shimizu, M., Grinde, B. (2001). Comparison of capsid sequences from human and animal astroviruses. J. Gen. Virol. 82: 1061-1067 [Abstract] [Full Text]  
  • Méndez-Toss, M., Romero-Guido, P., Munguía, M. E., Méndez, E., Arias, C. F. (2000). Molecular analysis of a serotype 8 human astrovirus genome. J. Gen. Virol. 81: 2891-2897 [Abstract] [Full Text]  
  • Imada, T., Yamaguchi, S., Mase, M., Tsukamoto, K., Kubo, M., Morooka, A. (2000). Avian Nephritis Virus (ANV) as a New Member of the Family Astroviridae and Construction of Infectious ANV cDNA. J. Virol. 74: 8487-8493 [Abstract] [Full Text]